Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

Some think investing in stocks requires substantial start-up capital, but that's false. Even with a modest sum, like $40, ...

The Graduate Aptitude Test-Biotechnology (GAT-B) 2025 application period is now open at exams.nta.ac.in/DBT, according to the ...

TScan Therapeutics is developing engineered T cell receptor therapies, with TSC-101 targeting HA-2 for acute leukemia. See ...

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of ...

The Wuhan company didn’t bother with the dark web. It spruiked its goods right in the open, showing mounds of white powder ...

In other instances, recombinant forms of certain therapeutic ... there were 369 biotechnology medicines in development in the US 3. Of these, almost half (175) were aimed at treating cancer ...

Kobo Biotech Ltd.(Formerly known Avon Lifesciences Ltd) was established as a Public Limited Company on August 3 1992. Effective 19th October 2020 ... 6 of IBBI CIRP Regulations 2016 the IRP published ...

Company Poised to Enter Booming Bispecific Antibody Market Amid Growing Pharma InterestProvidence, RI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ocean ...

Pfizer’s plans to duck out of central nervous system R&D have come to fruition, with the creation of spinout biotech Cerevel Therapeutics ... ready selective GABA 2/3 agonist which will ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

PDS Biotechnology (PDSB) reaffirmed the Company’s guidance of initiating its VERSATILE-003 Phase 3 clinical trial of Versamune HPV plus ...